drugset / Trial / NCT00651690

Study of Responsiveness of Seven Functional Tasks in Patients With Poststroke Upper Limb Spasticity With Botulinum Toxin Type A Treatment

NCT00651690 ↗

Phase 2 Completed 62 enrolled Allergan
RandomizedParallel-groupDouble-blindTreatment

Summary

This study evaluates the responsiveness of 7 functional tasks to botulinum toxin Type A treatment in poststroke patients with spasticity of the upper-limb flexors

Timeline

Start
2004-03
Primary completion
2005-05
Completion
2005-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 200 iu —
Subject Botulinum toxin type A Protein / enzyme biologic 360 iu —

Indications